Clinical Trial Update: Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial [Phase 2]

View source ↗

Summary

Phase II trial evaluating pazopanib for advanced or metastatic liposarcoma with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liposarcoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: Grupo Espanol de Investigacion en Sarcomas | Conditions: Advanced and / or Metastatic Liposarcoma | Phase 2 | Status: COMPLETED | Results posted: 2020-07-23